Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2025 and recent operational progress. “2026 is about building a steady cadence of biopsies and treatments, ...

Good morning, everyone, and welcome to the Abeona Therapeutics Full Year 2025 Results Conference Call. [Operator Instructions] Please note this conference is being recor ...

First ZEVASKYN- commercial patient treatment completed in December - - ZEVASKYN launch momentum building in first quarter 2026 - - $191.4M in cash, cash equivalents and short-term investments as of ...

Beyond Meat to delay filing annual report due to inventory accounting review. U.S. confirms $4.3B Tesla, LG battery deal. SK Group chairman warns memory chip shortage could last until 2030.

Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness -CUE-401 is the Company's lead asset for the treatment of autoimmune and inflammatory diseasesAppointed indust ...

Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.

Government rules out separate Pay Revision Committee for 8 lakh PSU non-executive staff in 2027. Latest Lok Sabha update on 4th PRC, 8th Pay Commission link & what it means for ONGC, NTPC employees.

Stephen Willard Stephen Willard, Chief Executive Officer, Longeveron Inc. (LGVN) On track for third quarter 2026 top-line ...

Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric cancer ...

Abinand Rangesh, CEO of Tecogen, commented "during the upcoming call, I will provide some significant positive updates that will include the scale of the Vertiv opportunity pipeline for our chillers, ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...

Star Equity Holdings, Inc. (Nasdaq: STRR and STRRP) ("Star" or the "Company"), a diversified holding company, announced today financial results for the fourth quarter and full year ended December 31, ...